ask="30.01"
ask_size="200"
average_daily_volume="490858"
bid="29.44"
bid_size="100"
book_value="6.19"
change="+0.43"
change_from_200_day_moving_average="-0.52"
change_from_50_day_moving_average="-2.26"
change_from_52_week_high="-9.48"
change_From_52_week_low="15.85"
change_in_percent="+1.48%"
close="29.44"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="29.58"
high_52_weeks="38.92"
last_trade_date="1/25/2017"
last_trade_price="29.44"
last_trade_size="8641"
last_trade_time="4:00pm"
low="28.48"
low_52_weeks="13.59"
market_capitalization="1.53B"
moving_average_200_day="29.96"
moving_average_50_day="31.70"
name="Theravance Biopharma
Inc. - Or"
notes="N/A"
one_year_target_price="34.71"
open="29.39"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-1.73%"
percent_change_from_50_day_moving_average="-7.13%"
percent_change_from_52_week_high="-24.36%"
percent_change_from_52_week_low="+116.63%"
previous_close="29.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.68"
price_per_sales="32.16"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="16.78"
stock_exchange="NGM"
symbol="TBPH"
volume="202674"
weeks_range_52="13.59 - 38.92"
